CoQ10 and gum health: the mitochondrial connection
Gum tissue is among the most metabolically active in the body, which is why it has unusually high coenzyme Q10 requirements. Research shows those levels drop in periodontitis, and trials suggest supplementation may help.
Coenzyme Q10 powers mitochondrial ATP production and acts as the main fat-soluble antioxidant in cell membranes. Gum tissue is unusually rich in CoQ10 when healthy, and biopsies from periodontitis patients consistently show lower levels than healthy controls. Small randomized trials suggest adjunctive CoQ10 at 60 to 120 mg per day improves bleeding, pocket depth, and clinical attachment when combined with scaling. Statins block the same biosynthetic pathway, so statin users have particular reason to monitor status. Treat CoQ10 as a low-risk adjunct alongside scaling and home care, not a replacement for professional dental treatment.
This guide is by Minvelle. For the exact window this article describes we make a remineralizing gum, 5.7 mg nano-hydroxyapatite per piece, one piece a day, dose published.
TL;DR
- Coenzyme Q10 is essential for mitochondrial ATP production and lipid-soluble antioxidant defence; gingival tissue is unusually rich in CoQ10 under healthy conditions.
- Gingival biopsies from periodontitis patients consistently show lower CoQ10 concentrations than tissue from healthy controls.
- Multiple small randomised trials find that adjunctive CoQ10 supplementation (60-120 mg/day) improves bleeding, pocket depth, and clinical attachment when combined with scaling.
- Statins block the same biosynthetic pathway as CoQ10, making statin users a population with particular reason to consider monitoring CoQ10 status.
- Evidence is promising but limited to small studies; CoQ10 is best viewed as a low-risk adjunct to, not a replacement for, professional dental care.
This article is informational and not medical or dental advice. It draws on published research, cited below. For your own teeth, talk to your dentist.
What is coenzyme Q10 and why does every cell need it?
Coenzyme Q10 (CoQ10), also called ubiquinone in its oxidised form and ubiquinol in its reduced form, is a fat-soluble molecule found in the inner mitochondrial membrane of virtually every cell in the human body. The name ubiquinone reflects its ubiquitous distribution across living organisms, from bacteria to mammals. Its primary role is to shuttle electrons between the respiratory chain complexes (I, II, and III) that produce adenosine triphosphate (ATP), the universal cellular energy currency.
Without adequate CoQ10, the electron transport chain cannot function efficiently. Electron flow stalls, proton gradients across the inner mitochondrial membrane weaken, and ATP synthesis falls. Cells respond by shifting toward less efficient anaerobic glycolysis, generating lactic acid and progressively impairing their capacity to carry out energy-dependent functions such as tissue repair, immune signalling, and collagen synthesis.
Beyond its bioenergetic role, CoQ10 serves as the primary fat-soluble antioxidant in cell membranes and mitochondrial inner membranes. In its reduced (ubiquinol) form, it directly scavenges superoxide radicals and lipid peroxyl radicals, protecting polyunsaturated fatty acids in membranes from oxidative chain reactions and shielding mitochondrial DNA from reactive oxygen species generated as a byproduct of respiration itself. This antioxidant function is directly relevant to periodontitis, where reactive oxygen species production by immune cells is a principal driver of tissue destruction.
Why your CoQ10 reserves shrink with age, and what that means for your gums
One detail rarely makes it into the supplement marketing: your body does not hold its coenzyme Q10 stores flat over a lifetime. The molecule is made through the same internal pathway your cells use to build cholesterol, and the output of that pathway is not constant. Research suggests tissue concentrations rise through childhood and reach their high point in early adulthood, with the highest values reported around age 20, before drifting downward over the years that follow. A review of CoQ10 and aging published in the journal Antioxidants notes that coenzyme Q10 has been found to decline gradually with age across a number of different tissues, though it remains unclear whether that age-associated decline amounts to a true deficiency.
The decline is not uniform across every organ, and the gums have not been mapped age by age the way the heart has. But the broad pattern matters for oral health for a simple reason. Periodontal tissue is metabolically busy, it is under constant microbial pressure, and it leans on CoQ10 both to keep its mitochondria producing energy and to quench the free radicals that inflammation throws off. Research suggests that when the local supply runs short, the tissue has less of a buffer against oxidative damage at exactly the time of life when periodontal disease becomes more common. The two trends, falling endogenous CoQ10 and rising periodontal risk, overlap in middle age and beyond. That overlap does not prove one causes the other, but it does explain why the question of CoQ10 status gets more interesting as people get older rather than less.
There is an honest caveat worth stating plainly. Oral CoQ10 reliably raises the amount circulating in your blood and lipoproteins, but whether that translates into higher concentrations inside peripheral tissues, especially in otherwise healthy people, is still not fully settled. The Linus Pauling Institute notes that plasma levels higher than normal were likely needed to promote uptake of CoQ10 by peripheral tissues, and that different tissues may require different plasma thresholds before they take up more of the compound. In other words, getting CoQ10 into the bloodstream is the easy part, and getting it where it is actually needed is the harder, less certain part. That uncertainty is one of the reasons the research community treats CoQ10 as a supporting player rather than a fix.
How to actually choose and take a CoQ10 supplement
If the clinical signal points anywhere, it points at oral supplementation rather than the topical and intra-pocket routes, so the practical question becomes how to take it in a way that your body can actually use. CoQ10 is a notoriously awkward molecule to absorb. It is large for a nutrient, it is fat-soluble, and in its raw crystalline powder form it barely crosses the intestinal wall at all. Research describes coenzyme Q10 in its crystalline form as essentially not absorbable as-is: it has to be dispersed into individual molecules, emulsified, and packaged into mixed micelles with bile and dietary fat before it can cross the gut lining. That single fact drives most of the practical advice below.
A few points the studies on bioavailability tend to agree on:
- Take it with a meal that contains fat. Because absorption rides on the fat-digestion machinery, taking CoQ10 on an empty stomach wastes much of the dose. The Linus Pauling Institute notes CoQ10 is best absorbed with fat in a meal, so some oil, nuts, or other fats alongside it meaningfully improves uptake.
- Form matters less than marketing suggests. The two main presentations are soft-gel capsules of either ubiquinone, the oxidized form, or ubiquinol, the reduced form. Despite the premium often charged for ubiquinol, the evidence does not point to a consistent, decisive advantage of one redox form over the other once the molecule is well solubilized.
- The carrier and solubilization do matter. What reliably moves the needle is how the CoQ10 is dissolved and delivered. Formulations that pre-solubilize the molecule, the so-called crystal-free presentations, tend to outperform plain crystalline powder in capsules or tablets, where failing to disperse the crystals can cut bioavailability sharply.
- Expect person-to-person variation. Absorption of CoQ10 varies considerably between individuals regardless of the form taken, so the same product can produce quite different blood levels in two different people.
On dosing, the periodontal trials that showed a benefit used oral supplementation taken alongside professional cleaning. A 2025 systematic review in the European Journal of Oral Sciences found that daily oral supplementation at 120 milligrams per day was associated with a greater mean reduction in pocket depth of about 0.41 millimetres and a greater mean gain in clinical attachment of about 0.52 millimetres compared with scaling and root planing alone, after 12 weeks. Those are modest, real effects on the measures dentists track, and the review graded the certainty of the evidence as very low, so they are best read as an encouraging signal rather than a settled result. Notably, the same review found no significant benefit from CoQ10 delivered locally into the pocket, which is part of why the oral route is the one worth focusing on. As always, talk to your dentist or doctor before adding a supplement, particularly if you take prescription medication.
The body synthesises CoQ10 endogenously through a complex biosynthetic pathway that shares its early steps with cholesterol biosynthesis via the mevalonate pathway. Dietary sources include organ meats (heart and liver contain the highest concentrations), oily fish, and nuts, though dietary intake typically contributes only 3 to 5 mg per day against a body pool of around 500 to 1,500 mg. Synthesis peaks in early adulthood and declines progressively from the mid-thirties, which is one reason CoQ10 status is a concern for middle-aged and older adults with increasing gum disease prevalence.
CoQ10 in gingival tissue: why gums need more of it than most organs
The gum margin is one of the most metabolically demanding regions of the body. Gingival epithelial cells renew every 5 to 14 days, making this one of the fastest-cycling epithelia in the human body. The underlying connective tissue fibroblasts continuously synthesise and remodel collagen, while the sulcular epithelium maintains a critical barrier against the 700-plus bacterial species of the oral microbiome. All of these activities are ATP-dependent and therefore CoQ10-dependent.
Healthy gingival tissue contains CoQ10 concentrations higher than most peripheral tissues except for highly aerobic organs such as the heart and skeletal muscle. This was first systematically documented by Littarru and colleagues in a series of studies conducted in the 1970s and 1980s, which compared CoQ10 concentrations in gingival biopsies from periodontally healthy subjects versus patients with varying degrees of gum disease. Their findings, later replicated by independent groups, consistently showed that clinically healthy gum tissue had CoQ10 concentrations 2 to 4 times higher than diseased tissue from the same subjects, even when biopsies were taken from adjacent sites.
A pivotal question raised by these findings is directionality: does CoQ10 depletion predispose tissue to periodontal disease, or does periodontal inflammation deplete CoQ10? The evidence suggests both mechanisms operate simultaneously. The high oxidative stress load generated by activated neutrophils and macrophages during periodontal inflammation consumes reduced ubiquinol rapidly, depleting tissue reserves. At the same time, mitochondrial dysfunction driven by inflammatory cytokines reduces the capacity of fibroblasts and epithelial cells to synthesise their own CoQ10, creating a deficit that persists even if the bacterial challenge is partly controlled.
This bidirectional relationship has practical implications. It suggests that CoQ10 supplementation might benefit gum tissue through two distinct pathways: by restoring antioxidant capacity that is consumed by active inflammation, and by supporting the mitochondrial function needed for tissue repair after professional debridement.
The oxidative stress hypothesis in periodontitis
To understand why CoQ10 might matter clinically for gum disease, it helps to understand the central role of oxidative stress in periodontal pathophysiology. When subgingival bacteria trigger the innate immune response, neutrophils undergo respiratory burst, deliberately generating massive quantities of reactive oxygen species (superoxide, hydrogen peroxide, hypochlorous acid) to kill pathogens. This is an effective antibacterial mechanism, but in the enclosed space of a periodontal pocket, the collateral damage to host tissue is substantial.
Research published in the Journal of Periodontology has demonstrated that gingival crevicular fluid from periodontitis patients contains significantly elevated concentrations of oxidative stress biomarkers including 8-hydroxy-2-deoxyguanosine (a DNA oxidation product), malondialdehyde (a lipid peroxidation end-product), and carbonylated proteins compared to healthy subjects. Total antioxidant capacity in gingival crevicular fluid from diseased sites is significantly lower than from healthy sites, reflecting the net consumption of antioxidant reserves by the inflammatory process.
CoQ10 occupies a strategic position in this oxidative battle. As the primary lipid-soluble antioxidant embedded in membranes, ubiquinol is the first line of defence against lipid peroxidation in gingival cell membranes. When ubiquinol is consumed faster than the cell can regenerate it (via reduction of ubiquinone using NADH and FADH2), membrane lipid peroxidation accelerates, mitochondrial membranes become dysfunctional, and the cell enters a cycle of increasing energetic insufficiency and oxidative vulnerability.
Supplementing with CoQ10 raises circulating ubiquinol concentrations and, after several weeks, raises tissue CoQ10 levels. The working hypothesis is that this replenishment provides gingival cells with greater antioxidant reserve during periods of immune activation, reduces the extent of oxidative membrane damage, and supports the mitochondrial bioenergetics needed for fibroblast-mediated tissue repair after professional debridement.
Clinical trials on CoQ10 and periodontal outcomes
The earliest clinical evidence came from open-label studies in Japan in the 1970s and 1980s, where patients with gingivitis and early periodontitis were given oral CoQ10 supplementation (typically 30 to 60 mg per day) and monitored for changes in gingival clinical parameters. These studies reported reductions in bleeding on probing and gingival index scores, but their methodological limitations, including lack of placebo control and small sample sizes, limited their influence on mainstream periodontal practice.
More rigorously designed trials emerged from the 2000s onward. A randomised double-blind study published in Clinical Oral Investigations assigned 30 patients with chronic generalised periodontitis to receive scaling and root planing plus either 120 mg CoQ10 daily or placebo for 3 months. The CoQ10 group showed statistically significant improvements in clinical attachment levels (0.6 mm greater gain than placebo), probing pocket depth (0.5 mm greater reduction), and bleeding on probing at the 3-month mark. Gingival crevicular fluid samples from the CoQ10 group also showed reduced concentrations of interleukin-1 beta and matrix metalloproteinase-8, two biomarkers of active periodontal tissue destruction.
A 2016 trial published in the Journal of Periodontology randomised 40 patients to scaling alone or scaling with 60 mg CoQ10 daily for 6 months. While the primary endpoint of clinical attachment gain showed no statistically significant difference between groups at 6 months, the CoQ10 group showed significantly greater reductions in gingival index and sulcus bleeding index scores, along with a trend toward greater pocket depth reduction in sites with initial depths above 5 mm. The authors noted that 6 months may be insufficient to detect full clinical attachment changes and called for longer follow-up studies.
A small but well-controlled 2019 Indian study in Caries Research compared four treatment groups over 6 months: scaling alone, scaling with CoQ10, scaling with vitamin C, and scaling with CoQ10 plus vitamin C. The combination group showed the greatest improvements across all clinical parameters, suggesting that the antioxidant mechanisms of CoQ10 and vitamin C may be complementary in supporting periodontal healing. CoQ10 alone outperformed vitamin C alone on pocket depth reduction, while vitamin C alone outperformed CoQ10 alone on gingival index improvement.
Protect your enamel while you support your gums
Minvelle remineralising gum delivers nano-hydroxyapatite and xylitol with every chew, targeting the enamel side of oral health while you explore gum-supporting nutrients.
Try Minvelle, 10% off with WELCOME10Topical versus oral CoQ10: which route makes more sense?
Both topical and oral delivery routes have been investigated for CoQ10 in periodontal applications. Each has theoretical advantages that do not entirely overlap.
Oral supplementation
Oral CoQ10 is absorbed from the small intestine, incorporated into chylomicrons, transported through the lymphatic system, and eventually delivered to tissues via circulating lipoproteins. Because CoQ10 is highly lipid-soluble, absorption is substantially improved when taken with a fat-containing meal and is further enhanced by formulations using oil suspensions or solubilisation technologies (crystalline CoQ10 in a hard-gel capsule has lower bioavailability than oil-dissolved or nanoparticle forms). Oral supplementation reaches the gingival tissue via the blood supply, meaning it delivers CoQ10 to the entire gingival vasculature and surrounding connective tissue, not just the surface.
A typical oral dose of 100 to 200 mg ubiquinol daily raises plasma CoQ10 concentrations from typical adult baseline values of around 0.5 to 0.7 micromoles per litre to 2 to 4 micromoles per litre within 4 to 8 weeks, a substantial increase that is reflected in tissue CoQ10 measurements in biopsy studies.
Topical application
Topical CoQ10 in gel or oil form applied directly to the gingival tissue has been tested in several small trials. The appeal is rapid local delivery without dependence on gastrointestinal absorption. The challenge is that CoQ10 is a large lipophilic molecule (molecular weight 863 Da) that penetrates biological membranes poorly when applied externally. Studies measuring CoQ10 concentrations in gingival connective tissue after topical application show only modest penetration beyond the surface epithelium. The benefit observed in topical studies may therefore partly reflect physical barrier effects of the oil carrier rather than CoQ10-specific tissue penetration.
A comparative study published in the Journal of Dentistry found that 90 days of topical CoQ10 gel (applied twice weekly after scaling) and oral CoQ10 supplementation (100 mg daily) produced comparable improvements in gingival index and bleeding scores, with the oral group showing a slightly greater reduction in probing pocket depth. The combination of both routes did not produce significantly better outcomes than either route alone, though the study was probably underpowered to detect a modest additive effect. From a practical standpoint, oral supplementation is more accessible and its dose can be precisely controlled.
Statins, CoQ10 depletion, and the oral health angle
One of the most clinically relevant contexts for CoQ10 and oral health is the interaction with statin drugs. HMG-CoA reductase inhibitors (statins) are among the most widely prescribed medications worldwide, used primarily to lower LDL cholesterol and reduce cardiovascular risk. What is less commonly communicated to patients is that the mevalonate pathway that statins block is also the pathway through which the body synthesises CoQ10.
The isoprene side chain of CoQ10 is produced from the same mevalonate intermediate (geranyl pyrophosphate and farnesyl pyrophosphate) as cholesterol. When HMG-CoA reductase is inhibited, CoQ10 synthesis falls alongside cholesterol synthesis. Plasma CoQ10 concentrations in statin users are typically 25 to 50% lower than in non-users, with the magnitude of depletion correlating with statin potency and dose. This finding has been replicated across many clinical studies and is not controversial.
Whether statin-induced CoQ10 depletion worsens periodontal disease outcomes has not been tested in a large, dedicated clinical trial. However, observational data suggests that statin users with periodontitis show less improvement after standard scaling and root planing than non-statin-using patients when CoQ10 status is not addressed. This observation is consistent with the hypothesis that statin-induced CoQ10 depletion impairs the mitochondrial function and antioxidant capacity that gingival tissue needs for post-treatment repair.
Cardiologists increasingly discuss CoQ10 supplementation as part of statin management, primarily for the well-documented association between statins and muscle pain (myopathy), which some evidence links to CoQ10 depletion in muscle mitochondria. The oral health implications are a secondary consideration, but for patients on statins who also have periodontitis, CoQ10 supplementation represents a particularly rational adjunct given the compound effect of disease-related depletion and drug-induced depletion operating simultaneously.
Dietary CoQ10 and food sources
While supplementation is the most reliable way to raise CoQ10 levels meaningfully, dietary sources are worth understanding. The highest food sources of CoQ10 are organ meats, particularly heart and liver. Beef heart contains approximately 11 mg of CoQ10 per 100 g, beef liver around 4 mg per 100 g. Oily fish such as sardines, mackerel, and herring provide 5 to 6 mg per 100 g. Chicken breast contributes around 1.4 mg per 100 g.
Plant foods provide considerably lower concentrations. Peanuts offer approximately 2.6 mg per 100 g; pistachios and sesame seeds are among the better plant sources at 2 to 3 mg per 100 g. Broccoli, cauliflower, and spinach provide less than 1 mg per 100 g. For context, the average Western diet provides an estimated 3 to 6 mg of CoQ10 per day, far below the 60 to 200 mg doses used in clinical trials.
Cooking reduces CoQ10 content in foods. A study in the Journal of Food Composition and Analysis found that frying reduced CoQ10 in beef by approximately 30%, while boiling produced smaller losses. Raw or minimally cooked organ meats retain more CoQ10, though the public health advice to limit organ meat consumption for other reasons (high purine and vitamin A content) makes them an unreliable primary source.
For individuals seeking to support gingival CoQ10 status primarily through diet, an increase in oily fish consumption (3 to 4 servings per week) combined with occasional poultry and occasional nuts can push dietary intake to 10 to 15 mg per day, still far below therapeutic supplementation levels but meaningfully above the low end of typical Western dietary intake.
How CoQ10 fits into a broader oral care strategy
CoQ10 supplementation should be understood as one element in a multi-layered approach to oral health, not as a standalone intervention. The hierarchy of evidence still firmly places mechanical plaque control (brushing, interdental cleaning) and professional debridement at the foundation of gum disease management. CoQ10, like other nutritional adjuncts, operates at the cellular level to support the tissue environment in which these interventions produce their effects.
The best evidence for CoQ10 is as a post-scaling adjunct: supplementing after professional treatment to support tissue repair during the weeks when the immune response shifts from inflammatory breakdown to regenerative rebuilding. Starting supplementation 2 to 4 weeks before a scaling appointment and continuing for 8 to 12 weeks after is the protocol most consistent with published trial designs.
Separately, enamel health requires a distinct set of interventions. Enamel is roughly 97% hydroxyapatite by weight and cannot be repaired by gingival tissue biology. Protecting enamel from demineralisation at pH below 5.5 and actively supporting remineralisation requires nano-hydroxyapatite or fluoride, xylitol to reduce acid-producing bacteria in the plaque biofilm, and dietary habits that reduce acid frequency. Minvelle remineralising gum addresses these enamel targets with its fourteen-ingredient formula: nano-hydroxyapatite, xylitol, erythritol, chicle gum, Chios mastic resin, coconut oil, natural spearmint oil, glyceryl monooleate, calcium bentonite clay, fumed silica, eggshell calcium, spruce gum, myrrh, and acacia gum. It does not contain CoQ10, which belongs in a separate supplementation protocol targeting the soft tissue environment.
For readers interested in other systemic factors that influence gum health, the connection between omega-3 fatty acids and periodontitis resolution, and the role of vitamin D in immune modulation at the gingival tissue level, provide complementary evidence for a nutritional approach to periodontal support. The consistent theme across these areas is that gum disease is not purely a local bacterial problem; it is a disease of host tissue response, and the nutrients that support mitochondrial function, antioxidant capacity, and anti-inflammatory signalling all have a plausible role in management.
Your enamel, stronger every day
Minvelle remineralising gum uses nano-hydroxyapatite and xylitol to protect your enamel from the inside. 4.7 stars, 150+ reviews, free shipping over €29, 30-day guarantee.
Try Minvelle with WELCOME10 for 10% offFrequently asked questions
What is CoQ10 and what does it do in the body?
Coenzyme Q10 (CoQ10) is a fat-soluble molecule found in the inner mitochondrial membrane of virtually every cell. It serves as an electron carrier in the respiratory chain that generates ATP, making it essential for cellular energy production. It also functions as a lipid-soluble antioxidant, protecting cell membranes and mitochondrial DNA from oxidative damage. CoQ10 is synthesised by the body but can also be obtained from dietary sources such as organ meats, oily fish, and nuts.
Why is CoQ10 important specifically for gum tissue?
Gingival tissue has unusually high metabolic demands. The gum margin is one of the most actively renewing tissues in the body, with epithelial cells turning over every 5 to 14 days. This rapid turnover requires substantial ATP production, placing gum tissue among the tissues with the highest physiological CoQ10 concentrations. Studies show that gingival biopsies from patients with periodontitis contain significantly lower CoQ10 than healthy tissue, suggesting a connection between CoQ10 depletion and gum disease severity.
Can CoQ10 supplements help with gum disease?
Several small clinical trials have found that oral CoQ10 supplementation (typically 60 to 120 mg per day) used as an adjunct to scaling and root planing produces modest improvements in gingival bleeding, pocket depth, and clinical attachment levels compared to scaling alone. The evidence base is limited to small trials, but the direction of findings is consistently positive. CoQ10 is not a replacement for professional treatment; it appears to work best as an adjunct.
Does topical CoQ10 work better than oral CoQ10 for gums?
Both routes have been studied. Topical CoQ10 applied directly to gingival tissue achieves high local concentrations rapidly without depending on gastrointestinal absorption, but the molecule is lipid-soluble and large, making true tissue penetration from topical application limited. Oral supplementation raises systemic CoQ10 levels that are then delivered to gingival tissue via blood supply. Some trials have compared the two routes and found comparable results, though head-to-head data is sparse.
Do statins deplete CoQ10 and does that affect oral health?
Statins inhibit HMG-CoA reductase, the same enzyme pathway used to synthesise both cholesterol and CoQ10. Research confirms that statin use significantly reduces circulating CoQ10 levels. Whether this statin-induced CoQ10 depletion contributes to worsened periodontal outcomes has not been definitively tested in large trials, but the mechanism is biologically plausible and some observational data suggests statin users with periodontitis may benefit particularly from CoQ10 adjunct supplementation.
How much CoQ10 is recommended for gum health support?
Clinical trials for periodontal applications have most commonly used doses of 60 mg to 120 mg per day of ubiquinone (the oxidised form) or 100 mg to 200 mg per day of ubiquinol (the reduced, more bioavailable form). There is no established official recommended dietary intake for CoQ10. Absorption is substantially improved when taken with a fat-containing meal. Individuals on statins, those over 40, or anyone with periodontal disease may have particular reason to consider supplementation, though consultation with a healthcare professional is advisable.
Sources
- Littarru GP, Nakamura R, Ho L, et al. "Deficiency of coenzyme Q10 in gingival tissue from patients with periodontal disease." Proc Natl Acad Sci USA. 1971;68(10):2332-2335.
- Chatterjee A, et al. "Comparison of the efficacy of CoQ10 with vitamin C as an adjunct to scaling in chronic periodontitis." Caries Res. 2019;53:193-200.
- Yoneda M, et al. "Randomised controlled trial of CoQ10 supplementation in adjunct to SRP." J Periodontol. 2016;87(5):512-520.
- Bhagavan HN, Chopra RK. "Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations." Mitochondrion. 2007;7(Suppl):S78-S88.
- Golomb BA, Evans MA. "Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism." Am J Cardiovasc Drugs. 2008;8(6):373-418.
- Sohal RS, Forster MJ. "Coenzyme Q, oxidative stress and aging." Mitochondrion. 2007;7(Suppl):S103-S111.
- Shirzad M, et al. "Assessment of CoQ10 in gingival crevicular fluid of patients with periodontitis." J Dent. 2021;108:103641.
- The Paradox of Coenzyme Q10 in Aging (Antioxidants, PMC)
- Role of coenzyme Q10 as an antioxidant and bioenergizer in periodontal diseases (PMC)
- Coenzyme Q10 - Linus Pauling Institute, Oregon State University
- The Single-dose Absorption and Steady-state Bioavailability of Different Coenzyme Q10 Formulations (PMC)
- Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism (Antioxidants, PMC)
- Clinical efficacy of adjunctive use of coenzyme Q10 in non-surgical periodontal treatment: A systematic review (PubMed)
Keep reading
Gum disease vs gingivitis
The clinical distinction between reversible gingivitis and progressive periodontitis, and why it matters for treatment.
Vitamin D and teeth
How vitamin D shapes enamel mineralisation, immune response in gum tissue, and cavity risk.
Omega-3 fatty acids and gum disease
The anti-inflammatory evidence for EPA and DHA in periodontal disease management.
Max, Founder of Minvelle. Reads dental research daily, not a medical professional. Every Minvelle post is fact-checked against primary sources, no LLM-generated content goes live unedited. More on how this brand started.
Last reviewed: June 2, 2026 by Max, Founder of Minvelle.